ScholarLens Back to search
2012•Xiandai yufang yixueRequires access

CLINICAL EFFICACY OF EDARAVONE ON THE TREATMENT OF ACUTE HEMORRHAGE IN 35 PATIENTS

Yang Xue-chua

Open publisher page 0 citations

Abstract

[Objective]To observe the clinical therapeutic effects of edaravone on acute cerebral hemorrhage.[Methods]70 patients were randomly divided into two groups,treatment group and control group.35 patients in the treatment group were given edaravone in addition to the routine therapy for 14 days and the other 35 patients were treated routinely for 14 days.Before and after 14 days,patients in 2 groups were recorded about neurological function deficit scores and efficacy assessment.[Results]14 days after the termination of the treatment,the neurological functional deficit scores in treatment group were much lower than that in control group(t = 2.75,P﹤0.05);effective rates in treatment group were significantly higher than those in control group(χ2 = 4.16,P﹤0.05).[Conclusion]Edaravone can cure acute cerebral hemorrhage safely and effectively.

About this research paper

What this paper is about

[Objective]To observe the clinical therapeutic effects of edaravone on acute cerebral hemorrhage.[Methods]70 patients were randomly divided into two groups,treatment group and control group.35 patients in the treatment group were given edaravone in addition to the routine therapy for 14 days and the other 35 patients were treated routinely for 14 days.Before and after 14 days,patients in 2 groups were recorded about neurological function deficit scores and efficacy assessment.[Results]14 days after the termination of the treatment,the neurological functional deficit scores in treatment group were much lower than that in control group(t = 2.75,P﹤0.05);effective rates in treatment group were significantly higher than those in control group(χ2 = 4.16,P﹤0.05).[Conclusion]Edaravone can cure acute cerebral hemorrhage safely and effectively.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective]To observe the clinical therapeutic effects of edaravone on acute cerebral hemorrhage.[Methods]70 patients were randomly divided into two groups,treatment group and control group.35 patients in the treatment group were given edaravone in addition to the routine therapy for 14 days and the other 35 patients were treated routinely for 14 days.Before and after 14 days,patients in 2 groups were recorded about neurological function deficit scores and efficacy assessment.[Results]14 days after the termination of the treatment,the neurological functional deficit scores in treatment group were much lower than that in control group(t = 2.75,P﹤0.05);effective rates in treatment group were significantly higher than those in control group(χ2 = 4.16,P﹤0.05).[Conclusion]Edaravone can cure acute cerebral hemorrhage safely and effectively.

Key concepts: Edaravone, Medicine, Neurological deficit, Clinical efficacy, Anesthesia, Treatment and control groups, Therapeutic effect, Conventional treatment

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
CLINICAL EFFICACY OF EDARAVONE ON THE TREATMENT OF ACUTE HEMORRHAGE IN 35 PATIENTS — Research Paper | ScholarLens